Patent · US Active

Methods and compositions for theranostic nanoparticles

US10973925B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignees

Inventors

Annette Khaled · Orlando, US
Jesus Manuel Perez Figueroa · Los Angeles, US
Santimukul Santra · Orlando, US
Charalambos Kaittanis · Cambridge, US
Oscar Santiesteban · El Segundo, US
Jan Grimm · Stintenberger Straße, CH
Hampton Sessions · Orlando, US

Key dates

Filing date	Apr 28, 2016
Grant date	Apr 13, 2021
Priority date	—
Expiry date	Sep 26, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compositions and methods for identifying a solid tumor cell target. Compositions and methods for treating prostate cancer are also disclosed. Further, cancer therapeutic compositions comprising CT20p are disclosed. Nanoparticles that are conjugated with a targeting ligand that is a substrate for a solid tumor-specific cell protein are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.